Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Copper

<< Previous

Bullboard Posts

Next >>

Comment by waynedon Oct 25, 2010 4:33pm

174 Views

Post# 17609256

RE: Copper

HudBay started trading on the New York Stock exchange today . I`m just reporting that as a point of interest . Any of our news releases concerning them will attract a lot more eyeballs . I have to say with the price of copper and especially zinc , I expected us to be doing better than this . With such a small volume traded , it only takes one weak hand bailing at the market to destroy two weeks of run up, as demonstrated last week. We need some strong news to get us past that stage.

<< Previous

Bullboard Posts

Next >>

HPQ Silicon updates shareholders on Fumed Silica Reactor developments